UBS Group’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.26M | Buy |
393,224
+45,419
| +13% | +$470K | ﹤0.01% | 4508 |
|
|
2025
Q4 | $4.3M | Sell |
347,805
-91,570
| -21% | -$981K | ﹤0.01% | 4179 |
|
|
2025
Q3 | $3.88M | Sell |
439,375
-44,605
| -9% | -$347K | ﹤0.01% | 4299 |
|
|
2025
Q2 | $3.09M | Sell |
483,980
-95,416
| -16% | -$546K | ﹤0.01% | 4363 |
|
|
2025
Q1 | $2.82M | Sell |
579,396
-10,825
| -2% | -$89.6K | ﹤0.01% | 4385 |
|
|
2024
Q4 | $5.64M | Buy |
590,221
+321,783
| +120% | +$2.95M | ﹤0.01% | 3694 |
|
|
2024
Q3 | $2.24M | Buy |
268,438
+11,480
| +4% | +$104K | ﹤0.01% | 3877 |
|
|
2024
Q2 | $1.75M | Sell |
256,958
-29,081
| -10% | -$125K | ﹤0.01% | 3899 |
|
|
2024
Q1 | $724K | Buy |
286,039
+82,879
| +41% | +$187K | ﹤0.01% | 4879 |
|
|
2023
Q4 | $488K | Buy |
203,160
+113,993
| +128% | +$268K | ﹤0.01% | 5133 |
|
|
2023
Q3 | $303K | Sell |
89,167
-120,384
| -57% | -$667K | ﹤0.01% | 5050 |
|
|
2023
Q2 | $1.54M | Sell |
209,551
-35,027
| -14% | -$325K | ﹤0.01% | 3800 |
|
|
2023
Q1 | $2.53M | Buy |
244,578
+36,606
| +18% | +$442K | ﹤0.01% | 3175 |
|
|
2022
Q4 | $2.46M | Buy |
207,972
+121,190
| +140% | +$1.88M | ﹤0.01% | 3193 |
|
|
2022
Q3 | $1.82M | Buy |
86,782
+15,642
| +22% | +$435K | ﹤0.01% | 3242 |
|
|
2022
Q2 | $2.21M | Sell |
71,140
-723
| -1% | -$24.7K | ﹤0.01% | 3068 |
|
|
2022
Q1 | $2.95M | Sell |
71,863
-85,131
| -54% | -$3.75M | ﹤0.01% | 3070 |
|
|
2021
Q4 | $6.82M | Buy |
156,994
+69,694
| +80% | +$3.15M | ﹤0.01% | 2507 |
|
|
2021
Q3 | $4.37M | Buy |
87,300
+56,468
| +183% | +$3.42M | ﹤0.01% | 2812 |
|
|
2021
Q2 | $1.94M | Sell |
30,832
-24,194
| -44% | -$1.55M | ﹤0.01% | 3602 |
|
|
2021
Q1 | $5.11M | Buy |
55,026
+20,793
| +61% | +$2.13M | ﹤0.01% | 2570 |
|
|
2020
Q4 | $3.07M | Sell |
34,233
-22,332
| -39% | -$2.05M | ﹤0.01% | 2956 |
|
|
2020
Q3 | $5.84M | Sell |
56,565
-11,449
| -17% | -$1.23M | ﹤0.01% | 2056 |
|
|
2020
Q2 | $5.38M | Buy |
68,014
+53,829
| +379% | +$4.01M | ﹤0.01% | 1987 |
|
|
2020
Q1 | $820K | Sell |
14,185
-45,648
| -76% | -$2.63M | ﹤0.01% | 3527 |
|
|
2019
Q4 | $3.23M | Sell |
59,833
-53,744
| -47% | -$2.91M | ﹤0.01% | 3054 |
|
|
2019
Q3 | $5.94M | Buy |
113,577
+86,105
| +313% | +$4.01M | ﹤0.01% | 2217 |
|
|
2019
Q2 | $1.33M | Sell |
27,472
-13,524
| -33% | -$648K | ﹤0.01% | 3506 |
|
|
2019
Q1 | $2.07M | Sell |
40,996
-43,816
| -52% | -$2.58M | ﹤0.01% | 2963 |
|
|
2018
Q4 | $5.03M | Buy |
84,812
+45,802
| +117% | +$2.95M | ﹤0.01% | 2148 |
|
|
2018
Q3 | $2.57M | Buy |
39,010
+12,153
| +45% | +$709K | ﹤0.01% | 3001 |
|
|
2018
Q2 | $1.36M | Sell |
26,857
-53,164
| -66% | -$2.77M | ﹤0.01% | 3511 |
|
|
2018
Q1 | $4.21M | Buy |
80,021
+51,895
| +185% | +$2.59M | ﹤0.01% | 2464 |
|
|
2017
Q4 | $1.31M | Sell |
28,126
-805
| -3% | -$33.9K | ﹤0.01% | 3550 |
|
|
2017
Q3 | $1.17M | Buy |
28,931
+10,503
| +57% | +$380K | ﹤0.01% | 3573 |
|
|
2017
Q2 | $626K | Sell |
18,428
-15,245
| -45% | -$471K | ﹤0.01% | 3962 |
|
|
2017
Q1 | $978K | Sell |
33,673
-2,385
| -7% | -$72.6K | ﹤0.01% | 3549 |
|
|
2016
Q4 | $1.19M | Buy |
36,058
+12,146
| +51% | +$364K | ﹤0.01% | 3408 |
|
|
2016
Q3 | $754K | Sell |
23,912
-5,861
| -20% | -$170K | ﹤0.01% | 3615 |
|
|
2016
Q2 | $837K | Buy |
29,773
+16,254
| +120% | +$637K | ﹤0.01% | 3530 |
|
|
2016
Q1 | $492K | Sell |
13,519
-1,342
| -9% | -$47.4K | ﹤0.01% | 3793 |
|
|
2015
Q4 | $595K | Buy |
14,861
+5,354
| +56% | +$187K | ﹤0.01% | 3806 |
|
|
2015
Q3 | $271K | Sell |
9,507
-4,763
| -33% | -$157K | ﹤0.01% | 4392 |
|
|
2015
Q2 | $470K | Buy |
14,270
+8,148
| +133% | +$253K | ﹤0.01% | 4177 |
|
|
2015
Q1 | $176K | Buy |
6,122
+5,384
| +730% | +$154K | ﹤0.01% | 4983 |
|
|
2014
Q4 | $20K | Buy |
+738
| New | +$17.6K | ﹤0.01% | 7658 |
|
Other funds holding EBS
VCM
PCM
VPM